Verrica Pharmaceuticals Inc. (VRCA) › Operating IncomeVerrica Pharmaceuticals Inc. (VRCA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$4.46M2018: -$21.88M2019: -$30.08M2020: -$40.18M2021: -$30.91M2022: -$21.30M2023: -$65.76M2024: -$65.92M2025: -$12.19M-$12.19M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$12.19M+81.5%2024-$65.92M-0.2%2023-$65.76M-208.8%2022-$21.30M+31.1%2021-$30.91M+23.1%2020-$40.18M-33.6%2019-$30.08M-37.5%2018-$21.88M-390.9%2017-$4.46M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share